EU nod for first long-acting HIV injectable treatment
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
22nd December 2020
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
22nd December 2020
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
22nd December 2020
New medicine tezepelumab is being studied in severe asthma
22nd December 2020
Follows positive opinion issued by EMA's CHMP
22nd December 2020
Treatment demonstrated non-inferior visual acuity gains compared to Regeneron's Eylea
21st December 2020
Drug becomes first treatment for peanut allergy in the EU
21st December 2020
Company will immediately begin delivering doses to the US government
21st December 2020
EGFR-TKI approved in the US for early non-small cell lung cancer
21st December 2020
SN14 will be advanced through further development and clinical trials
18th December 2020
British pharma company also announces strategic collaboration agreement
18th December 2020
Danish pharma is seeking approval for drug as a weight management therapy
18th December 2020
Specialist help will be available at 69 sites across the country
18th December 2020
Flying the flag for excellence in global clinical research, the prestigious PharmaTimes International Clinical Researcher of the Year opens its doors for entry.
17th December 2020
Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome
17th December 2020
Consortium is led by Cambridge Medical Research Council (MRC) researchers
17th December 2020